Lena Weiss, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Florian Kaiser, Martin Fuchs, Gerald W. Prager, Kathrin Heinrich, Andreas Dickhut, Ralf Hofheinz, Thomas Decker, Stefan Angermeier, Tom Ganten, Christof Burkart, Matthias Sandmann, Leopold Öhler, Dora Niedersuess-Beke, Thomas Kubin, Dominik Paul Modest, Swantje Held, Volker Heinemann. "FIRE-4 (AIO KRK-0114): Efficacy of third-line rechallenge with cetuximab versus investigator’s choice in relation to the interval between initial and third-line anti-EGFR therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3575